Baillie Gifford & Co. Grows Stock Position in Astera Labs, Inc. $ALAB

Baillie Gifford & Co. lifted its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 9.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 252,913 shares of the company’s stock after buying an additional 22,126 shares during the period. Baillie Gifford & Co. owned approximately 0.15% of Astera Labs worth $42,075,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of ALAB. Assetmark Inc. increased its holdings in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares during the period. Hilltop National Bank increased its holdings in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the period. Aventura Private Wealth LLC purchased a new position in shares of Astera Labs in the fourth quarter worth about $33,000. National Bank of Canada FI increased its holdings in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares during the period. Finally, Wexford Capital LP purchased a new position in shares of Astera Labs in the third quarter worth about $39,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Company commentary and investor notes point to “high double‑digit” growth expectations and recent headlines highlight a strong weekly rally, which has drawn fresh buyer interest. Astera Labs (ALAB) Eyes ‘High Double-Digit Growth,’ Soars 27%
• Positive Sentiment: Unusually high call‑option volume signals speculative bullish positioning and may amplify near‑term upside as traders hedge or lever directional bets. Traders Purchase High Volume of Call Options on Astera Labs (NASDAQ:ALAB)
• Positive Sentiment: An institutional investor (Diversify Advisory Services LLC) increased its stake, a vote of confidence that can support demand and signal conviction to other funds. Diversify Advisory Services LLC Grows Position in Astera Labs, Inc. $ALAB
• Positive Sentiment: Astera appears on lists of top growth stocks with strong insider ownership, which can attract momentum and retail/ETF flows in a growth‑friendly market backdrop. April 2026’s Top Growth Companies With Strong Insider Ownership
• Neutral Sentiment: Broad market volatility—S&P futures reacting to higher inflation and rising oil—creates a mixed macro backdrop that could amplify swings in high‑beta names like ALAB. US Stock Market Today S&P 500 Futures Slip As Inflation And Oil Jitters Build
• Negative Sentiment: Citi cut its price target from $250 to $200 (but kept a Buy rating), signaling less upside than before and providing a reason for more cautious positioning among some growth investors. Citi Lowered PT on Astera Labs (ALAB), Is It Still the Best Growth Stock?
• Negative Sentiment: Analyst commentary (reflected in Zacks/Yahoo pieces) notes that recent EPS estimate revision trends do not support continued strength, implying the recent rally may be driven more by positioning than by fresh upside to fundamentals. Astera Labs, Inc. (ALAB) Soars 15.1%: Is Further Upside Left in the Stock?

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $166.79 on Tuesday. Astera Labs, Inc. has a 1 year low of $52.56 and a 1 year high of $262.90. The company has a market cap of $28.56 billion, a PE ratio of 136.71, a P/E/G ratio of 2.93 and a beta of 1.78. The stock’s 50-day moving average is $128.40 and its 200 day moving average is $154.49.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the previous year, the business earned $0.37 EPS. Astera Labs’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Royal Bank Of Canada assumed coverage on Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective on the stock. Barclays set a $165.00 price objective on Astera Labs in a report on Thursday, January 15th. Loop Capital assumed coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Finally, Citigroup assumed coverage on Astera Labs in a report on Thursday, April 2nd. They set a “buy” rating and a $200.00 price target on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $199.44.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 157,500 shares of Astera Labs stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $131.58, for a total transaction of $20,723,850.00. Following the sale, the chief executive officer directly owned 4,531,732 shares of the company’s stock, valued at approximately $596,285,296.56. The trade was a 3.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 577,292 shares of company stock worth $69,495,249 over the last 90 days. 12.50% of the stock is owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.